Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 45:369-376, doi:10.1016/j.jacc.2004.10.041
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v45,p1912)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cowper, P. A.
Right arrow Articles by Peterson, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cowper, P. A.
Right arrow Articles by Peterson, E. D.

Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention

Patricia A. Cowper, PhD*,{dagger},*, Krishna Udayakumar, MD, MBA{dagger}, Michael H. Sketch, Jr, MD{dagger} and Eric D. Peterson, MD, MPH, FACC*,{dagger}

* Outcomes Research and Assessment Group, Duke Clinical Research Institute
{dagger} Duke University Medical Center, Durham, North Carolina



View larger version (25K):

[in a new window]
 
Figure 1 Decision model subtree for no clopidogrel arm. A parallel subtree exists for the treatment arm. Circles = chance nodes; arrowheads = terminal nodes. Revasc = revascularization.

 


View larger version (23K):

[in a new window]
 
Figure 2 Cost-effectiveness of prolonged clopidogrel therapy: sensitivity to variation in relative risk for myocardial infarction (MI). The cost per year of life saved is shown for values of relative risk for MI between 0 and 1. Solid line without symbols = all patients; line with triangles = high-risk patients; line with circles = low-risk patients. Baseline value of relative risk for MI is indicated by the vertical dotted line.

 


View larger version (20K):

[in a new window]
 
Figure 3 Cost-effectiveness of prolonged clopidogrel therapy: sensitivity to variation in price of clopidogrel. The cost per year of life saved is shown for clopidogrel prices between $0 and $4 per day. Solid line without symbols = all patients; line with triangles = high-risk patients; line with circles = low-risk patients. Baseline value for daily price of clopidogrel is indicated by the vertical dotted line.

 


View larger version (20K):

[in a new window]
 
Figure 4 Cost-effectiveness of prolonged clopidogrel therapy: sensitivity to variation in estimate of the reduction in life expectancy associated with myocardial infarction (MI). The cost per year of life saved is shown for a range of values of reduction in life expectancy subsequent to MI. Solid line without symbols = all patients; line with triangles = high-risk patients; line with circles = low-risk patients. Baseline value for reduction in life expectancy due to MI is indicated by the vertical dotted line.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement